11 results
20-F
2021 FY
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
and a principal investigator has created a conflict of interest or otherwise affected interpretation of the study. The FDA, the NMPA or a comparable foreign
424B4
CNTB
Connect Biopharma Holdings Ltd
19 Mar 21
Prospectus supplement with pricing info
4:49pm
authority may conclude that a financial relationship between us and a principal investigator has created a conflict of interest or otherwise affected
F-1/A
CNTB
Connect Biopharma Holdings Ltd
18 Mar 21
Registration statement (foreign) (amended)
6:15am
foreign regulatory authority may conclude that a financial relationship between us and a principal investigator has created a conflict of interest or otherwise
F-1/A
EX-10.2
q8uwjt
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
x448nictn 7l
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-99.1
3ui57 jmm4549k1o9zmf
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
6n0vbrq0m mn
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
415 k05yc9vj2yfs1td
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
8ggv tgtou2rsna
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next